CoChat
Sign Up
Cited by 87

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Downregulation of miR-132/212 impairs S-nitrosylation balance and induces tau phosphorylation in Alzheimer's disease

Wang, Yang, Veremeyko, Tatiana, Wong, Andus Hon-Kit, El Fatimy, Rachid, Wei, Zhiyun, Cai, Wei, Krichevsky, Anna M.·2017·Neurobiology of Aging
DOI 10.1016/j.neurobiolaging.2016.12.015
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2016.12.015

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • miR-212-5p was found decreased in several other neurodegenerative diseases such as AD, Huntington's disease, and PD.

    “Moreover, miR-212-5p was found decreased in several other neurodegenerative diseases such as AD, Huntington’s disease, and PD [62, 66, 69–75], indicating a key role in neurodegenerative diseases.”

    From A role for astrocytic miR-129-5p in frontotemporal dementia (2025) · cites this paper as [71]

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 35

  1. Absalon, 2013, MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons, J. Neurosci., 33, 14645, 10.1523/JNEUROSCI.1327-13.2013 · DOI · Paper page
  2. Chen-Plotkin, 2012, TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways, J. Neurosci., 32, 11213, 10.1523/JNEUROSCI.0521-12.2012 · DOI · Paper page
  3. Cho, 2009, S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury, Science, 324, 102, 10.1126/science.1171091 · DOI · Paper page
  4. Chow, 2014, CDK5 activator protein p25 preferentially binds and activates GSK3beta, Proc. Natl. Acad. Sci. U. S. A., 111, E4887, 10.1073/pnas.1402627111 · DOI
  5. Galimberti, 2008, Association of a NOS1 promoter repeat with Alzheimer's disease, Neurobiol. Aging, 29, 1359, 10.1016/j.neurobiolaging.2007.03.003 · DOI
  6. Haley, 1992, The role of nitric oxide in hippocampal long-term potentiation, Neuron, 8, 211, 10.1016/0896-6273(92)90288-O · DOI
  7. Han, 2013, Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5p, Genes Dev., 27, 485, 10.1101/gad.207456.112 · DOI
  8. Hara, 2005, S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding, Nat. Cell Biol., 7, 665, 10.1038/ncb1268 · DOI
  9. Hebert, 2013, A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls, J. Alzheimers Dis., 35, 335, 10.3233/JAD-122350 · DOI · Paper page
  10. Hernandez-Rapp, 2016, MicroRNAs underlying memory deficits in neurodegenerative disorders, Prog. Neuropsychopharmacol. Biol. Psychiatry, 73, 79, 10.1016/j.pnpbp.2016.04.011 · DOI
  11. Hu, 2012, Evolution of the human-specific microRNA miR-941, Nat. Commun., 3, 1145, 10.1038/ncomms2146 · DOI
  12. Izumi, 1992, Inhibition of long-term potentiation by NMDA-mediated nitric oxide release, Science, 257, 1273, 10.1126/science.1519065 · DOI
  13. Jahani-Asl, 2015, CDK5 phosphorylates DRP1 and drives mitochondrial defects in NMDA-induced neuronal death, Hum. Mol. Genet., 24, 4573, 10.1093/hmg/ddv188 · DOI
  14. Jasinska, 2016, miR-132 regulates dendritic spine structure by direct targeting of matrix metalloproteinase 9 mRNA, Mol. Neurobiol., 53, 4701, 10.1007/s12035-015-9383-z · DOI
  15. Kim, 2016, Phosphorylation of CHIP at Ser20 by Cdk5 promotes tAIF-mediated neuronal death, Cell Death Differ., 23, 333, 10.1038/cdd.2015.103 · DOI
  16. Ko, 2001, p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment, J. Neurosci., 21, 6758, 10.1523/JNEUROSCI.21-17-06758.2001 · DOI
  17. Krichevsky, 2001, Neuronal RNA granules: a link between RNA localization and stimulation-dependent translation, Neuron, 32, 683, 10.1016/S0896-6273(01)00508-6 · DOI
  18. Lau, 2013, Alteration of the microRNA network during the progression of Alzheimer's disease, EMBO Mol. Med., 5, 1613, 10.1002/emmm.201201974 · DOI · Paper page
  19. Luth, 2002, Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation, Brain Res., 953, 135, 10.1016/S0006-8993(02)03280-8 · DOI
  20. Magill, 2010, microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus, Proc. Natl. Acad. Sci. U. S. A., 107, 20382, 10.1073/pnas.1015691107 · DOI · Paper page
  21. McLoughlin, 2014, Human-specific microRNA regulation of FOXO1: implications for microRNA recognition element evolution, Hum. Mol. Genet., 23, 2593, 10.1093/hmg/ddt655 · DOI
  22. Mellios, 2011, miR-132, an experience-dependent microRNA, is essential for visual cortex plasticity, Nat. Neurosci., 14, 1240, 10.1038/nn.2909 · DOI · Paper page
  23. Meuer, 2007, Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis, Cell Death Differ., 14, 651, 10.1038/sj.cdd.4402087 · DOI
  24. Mondragon-Rodriguez, 2014, Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome, Neuropathol. Appl. Neurobiol., 40, 121, 10.1111/nan.12084 · DOI
  25. Nakamura, 2013, Aberrant protein s-nitrosylation in neurodegenerative diseases, Neuron, 78, 596, 10.1016/j.neuron.2013.05.005 · DOI
  26. Piscopo, 2016, Frontotemporal lobar degeneration and MicroRNAs, Front Aging Neurosci., 8, 17, 10.3389/fnagi.2016.00017 · DOI
  27. Qu, 2011, S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide, Proc. Natl. Acad. Sci. U. S. A., 108, 14330, 10.1073/pnas.1105172108 · DOI
  28. Reif, 2011, Association of a functional NOS1 promoter repeat with Alzheimer's disease in the VITA cohort, J. Alzheimers Dis., 23, 327, 10.3233/JAD-2010-101491 · DOI
  29. Seneviratne, 2016, S-nitrosation of proteins relevant to Alzheimer's disease during early stages of neurodegeneration, Proc. Natl. Acad. Sci. U. S. A., 113, 4152, 10.1073/pnas.1521318113 · DOI
  30. Smith, 2011, MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy, Hum. Mol. Genet., 20, 4016, 10.1093/hmg/ddr330 · DOI · Paper page
  31. Smith, 2015, miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo, Hum. Mol. Genet., 24, 6721, 10.1093/hmg/ddv377 · DOI · Paper page
  32. Tenreiro, 2014, Protein phosphorylation in neurodegeneration: friend or foe?, Front Mol. Neurosci., 7, 42, 10.3389/fnmol.2014.00042 · DOI · Paper page
  33. Wanet, 2012, miR-212/132 expression and functions: within and beyond the neuronal compartment, Nucleic Acids Res., 40, 4742, 10.1093/nar/gks151 · DOI
  34. Weishaupt, 2003, Cyclin-dependent kinase 5 (CDK5) and neuronal cell death, Cell Tissue Res., 312, 1, 10.1007/s00441-003-0703-7 · DOI
  35. Wong, 2013, De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease, Hum. Mol. Genet., 22, 3077, 10.1093/hmg/ddt164 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Wang, Y., Veremeyko, T., Wong, A. H.-K., El Fatimy, R., Wei, Z., Cai, W., & Krichevsky, A. M.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2017-03
Volume
51
Pages
156-166
ISSN
0197-4580
DOI
10.1016/j.neurobiolaging.2016.12.015
Cited by
87
References
7
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • Alzheimer's Association (NIRG-09-132844)
  • Tau Consortium
  • Rainwater Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review